Symbiq Infusion Systems Have Cybersecurity Vulnerabilities, FDA Warns
The Symbiq infusion pump may be vulnerable to hacking attempts that could lead to drug overdoses or lack of treatment, federal and company officials warn.
The Symbiq infusion pump may be vulnerable to hacking attempts that could lead to drug overdoses or lack of treatment, federal and company officials warn.
Federal regulators have warned Hospira Inc. over the quality of its medical devices, following an inspection of its Lake Forest, Illinois production facility.
A Class one recalled has been issued for one and two channel Symbiq infusion systems sold by Hospira, due to the potential risk that the pump may administer too much…
Hospira has received an FDA warning letter over conditions at an infusion pump factory in Costa Rica, which the agency has deemed to be unacceptable.
Problems with Hospira’s Symbiq infusion pumps have resulted in a Class 1 recall this week for two models of infusion sets, as a product defect could cause patients to suffer…